Production (Stage)
BioAge Labs, Inc.
BIOA
$3.98
$0.030.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.45M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.45M | -- | -- | -- | -- |
| Cost of Revenue | 11.11M | -- | -- | -- | 9.32M |
| Gross Profit | -9.66M | -- | -- | -- | -9.32M |
| SG&A Expenses | 6.79M | 6.14M | 4.73M | 4.80M | 3.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.90M | 25.36M | 24.75M | 15.27M | 12.81M |
| Operating Income | -16.45M | -25.36M | -24.75M | -15.27M | -12.81M |
| Income Before Tax | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.93M | -21.13M | -23.41M | -13.58M | -12.99M |
| EBIT | -16.45M | -25.36M | -24.75M | -15.27M | -12.81M |
| EBITDA | -16.41M | -25.32M | -24.71M | -15.22M | -12.78M |
| EPS Basic | -0.36 | -0.59 | -6.70 | -7.94 | -7.76 |
| Normalized Basic EPS | -0.23 | -0.37 | -4.19 | -4.96 | -4.76 |
| EPS Diluted | -0.36 | -0.59 | -6.70 | -7.94 | -7.76 |
| Normalized Diluted EPS | -0.23 | -0.37 | -4.19 | -4.96 | -4.76 |
| Average Basic Shares Outstanding | 35.85M | 36.01M | 3.49M | 1.71M | 1.67M |
| Average Diluted Shares Outstanding | 35.85M | 36.01M | 3.49M | 1.71M | 1.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |